Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avalo Therapeutics Inc

4.10
-0.2300-5.31%
Post-market: 4.01-0.0900-2.20%18:02 EDT
Volume:89.04K
Turnover:377.52K
Market Cap:44.39M
PE:-0.84
High:4.49
Open:4.33
Low:4.06
Close:4.33
Loading ...

Avalo Therapeutics: Enters $75 Million Sales Agreement With TD Cowen for Common Stock Offering - SEC Filing

THOMSON REUTERS
·
Yesterday

Avalo Therapeutics Inc. Enters $75 Million Sales Agreement with TD Cowen for Common Stock Offering

Reuters
·
Yesterday

Avalo Therapeutics Inc. Unveils Presentation Highlighting Advancements in Targeted Therapies for Immune Mediated Inflammatory Diseases

Reuters
·
04 Jun

Avalo Therapeutics Inc : H.c. Wainwright Assumes Coverage With Buy Rating; Target Price $15

THOMSON REUTERS
·
02 Jun

Avalo Therapeutics assumed with a Buy at H.C. Wainwright

TIPRANKS
·
02 Jun

Avalo Therapeutics Q1 2025 EPS $(1.25) Beats $(1.39) Estimate, Cash On Hand Of Approximately $125 As Of March 31, 2025 Expected To Provide Runway Into 2027, With Optionality To Extend Into 2028

Benzinga
·
12 May

Press Release: Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates

Dow Jones
·
12 May

Avalo Therapeutics Inc expected to post a loss of $1.39 a share - Earnings Preview

Reuters
·
10 May

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
08 May

Avalo Therapeutics to Participate in The Citizens Life Sciences Conference

GlobeNewswire
·
30 Apr

Avalo Therapeutics Names Michael Heffernan as Board Chairman

MT Newswires Live
·
26 Mar

BRIEF-Avalo Therapeutics Appoints Michael Heffernan As Chairman Of The Board

Reuters
·
26 Mar

Avalo Therapeutics - Garry Neil to Remain as CEO and Board Member

THOMSON REUTERS
·
26 Mar

Press Release: Avalo Therapeutics Appoints Michael Heffernan as Chairman of the Board

Dow Jones
·
26 Mar

Promising Outlook for Avalo Therapeutics’ AVTX-009 in HS Treatment

TIPRANKS
·
25 Mar

Avalo Therapeutics Inc : Jefferies Initiates Coverage With Buy Rating; Price Target $23

THOMSON REUTERS
·
25 Mar

Oppenheimer Remains a Buy on Avalo Therapeutics (AVTX)

TIPRANKS
·
24 Mar

Avalo Therapeutics (AVTX) Receives a Hold from H.C. Wainwright

TIPRANKS
·
21 Mar

Avalo Therapeutics FY Pretax Profit USD -35.015 Million

THOMSON REUTERS
·
20 Mar

Press Release: Avalo Reports 2024 Financial Results and Recent Business Updates

Dow Jones
·
20 Mar